v3.26.1
Fair Value Measurements - Summary of Financial Assets Recognized at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Marketable securities:    
Investment in Kyverna Therapeutics, Inc. $ 10,130 $ 11,034
Fair Value on Recurring Basis [Member]    
Assets    
Cash equivalents and restricted cash equivalents 79,145 92,263
Marketable securities:    
Total marketable securities 382,550 449,670
Investment in Kyverna Therapeutics, Inc. 10,130 11,034
Total Assets 471,825 552,967
Fair Value on Recurring Basis [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 191,841 221,117
Fair Value on Recurring Basis [Member] | Financial Institution Debt Securities [Member]    
Marketable securities:    
Total marketable securities 116,544 146,815
Fair Value on Recurring Basis [Member] | Corporate Debt Securities [Member]    
Marketable securities:    
Total marketable securities 74,165 81,738
Fair Value on Recurring Basis [Member] | Level 1 [Member]    
Assets    
Cash equivalents and restricted cash equivalents 79,145 92,263
Marketable securities:    
Total marketable securities 129,324 150,852
Investment in Kyverna Therapeutics, Inc. 10,130 11,034
Total Assets 218,599 254,149
Fair Value on Recurring Basis [Member] | Level 1 [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 129,324 150,852
Fair Value on Recurring Basis [Member] | Level 2 [Member]    
Marketable securities:    
Total marketable securities 253,226 298,818
Total Assets 253,226 298,818
Fair Value on Recurring Basis [Member] | Level 2 [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 62,517 70,265
Fair Value on Recurring Basis [Member] | Level 2 [Member] | Financial Institution Debt Securities [Member]    
Marketable securities:    
Total marketable securities 116,544 146,815
Fair Value on Recurring Basis [Member] | Level 2 [Member] | Corporate Debt Securities [Member]    
Marketable securities:    
Total marketable securities $ 74,165 $ 81,738